Office of National Drug Control Policy Reauthorization Act of 2024
Summary
Office of National Drug Control Policy Reauthorization Act of 2024
This bill reauthorizes through FY2031 the Office of National Drug Control Policy and related grants, programs, and initiatives such as
- the High Intensity Drug Trafficking Areas program,
- the Drug-Free Communities program,
- the Drug Court Training and Technical Assistance program, and
- the National Community Anti-Drug Coalition Institute.
Lifecycle of the Bill
On Motion to Suspend the Rules and Pass, as Amended
On Motion to Suspend the Rules and Pass, as Amended
The House of Representatives voted to pass H.R. 9598, the Office of National Drug Control Policy Reauthorization Act of 2024. This legislation extends the operations of the federal office responsible for coordinating the nation's drug control efforts, including the development of the National Drug Control Strategy and the oversight of programs aimed at reducing illicit drug use and trafficking. The vote was conducted under a suspension of the rules, a procedure typically reserved for non-controversial bills that requires a two-thirds majority for passage. The result was nearly unanimous, with 399 members voting in favor and only one member voting against. This overwhelming bipartisan support demonstrates a strong consensus between Democrats and Republicans regarding the continuation of federal drug policy coordination. By passing this bill, the House has signaled its commitment to maintaining the administrative framework used to combat the ongoing opioid crisis and other substance abuse challenges facing the country. Because the bill passed the House with an amendment, it now moves to the Senate for further consideration. If the Senate passes the legislation in the same form, it will be sent to the President to be signed into law. This reauthorization ensures that the Office of National Drug Control Policy can continue its mission without a lapse in its legal mandate or organizational structure.
